<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRYAA</id>
	<title>CRYAA - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=CRYAA"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRYAA&amp;action=history"/>
	<updated>2026-04-05T05:44:00Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=CRYAA&amp;diff=6271&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Contains: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)] [CRYA1] [...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=CRYAA&amp;diff=6271&amp;oldid=prev"/>
		<updated>2021-05-12T15:20:35Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Contains: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)] [CRYA1] [...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Contains: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)] [CRYA1] [HSPB4]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Polymorphism rs7278468 is associated with Age-related cataract through decreasing transcriptional activity of the [[CRYAA]] promoter.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26984531&lt;br /&gt;
|abstract=[[CRYAA]] plays critical functional roles in lens transparency and opacity, and polymorphisms near [[CRYAA]] have been associated with age-related cataract ([[ARC]]). This study examines polymorphisms in the [[CRYAA]] promoter region for association with [[ARC]] and elucidates the mechanisms of this association. Three SNPs nominally associated with [[ARC]] were identified in the promoter region of [[CRYAA]]: rs3761382 (P = 0.06, OR (Odds ratio) = 1.5), rs13053109 (P = 0.04, OR = 1.6), rs7278468 (P = 0.007, OR = 0.6). The C-G-T haplotype increased the risk for [[ARC]] overall (P = 0.005, OR = 1.8), and both alleles and haplotypes show a stronger association with cortical cataract (rs3761382, P = 0.002, OR = 2.1; rs13053109, P = 0.002, OR = 2.1; rs7278468, P = 0.0007, OR = 0.5; C-G-T haplotype, P = 0.0003, OR = 2.2). The C-G-T risk haplotype decreased transcriptional activity through rs7278468, which lies in a consensus binding site for the transcription repressor [[KLF10]]. [[KLF10]] binding inhibited [[CRYAA]] transcription, and both binding and inhibition were greater with the T rs7278468 allele. Knockdown of [[KLF10]] in HLE cells partially rescued the transcriptional activity of [[CRYAA]] with rs7278468 T allele, but did not affect activity with the G allele. Thus, our data suggest that the T allele of rs7278468 in the [[CRYAA]] promoter is associated with [[ARC]] through increasing binding of KLF-10 and thus decreasing [[CRYAA]] transcription. &lt;br /&gt;
|mesh-terms=* Aged&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* Alleles&lt;br /&gt;
* Binding Sites&lt;br /&gt;
* Case-Control Studies&lt;br /&gt;
* Cataract&lt;br /&gt;
* Cell Line&lt;br /&gt;
* Crystallins&lt;br /&gt;
* Early Growth Response Transcription Factors&lt;br /&gt;
* Female&lt;br /&gt;
* Genotype&lt;br /&gt;
* Haplotypes&lt;br /&gt;
* Humans&lt;br /&gt;
* Kruppel-Like Transcription Factors&lt;br /&gt;
* Linkage Disequilibrium&lt;br /&gt;
* Male&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Odds Ratio&lt;br /&gt;
* Polymorphism, Single Nucleotide&lt;br /&gt;
* Promoter Regions, Genetic&lt;br /&gt;
* Protein Binding&lt;br /&gt;
* RNA Interference&lt;br /&gt;
* RNA, Small Interfering&lt;br /&gt;
* Transcription, Genetic&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794711&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A novel mutation (F71L) in alphaA-crystallin with defective chaperone-like function associated with age-related cataract.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/19595763&lt;br /&gt;
|abstract=Age-related cataract ([[ARC]]) is a multifactorial disease and the leading cause of blindness worldwide. Genetic predisposition in association with other etiological factors may contribute to [[ARC]]. However, gene mutation studies on [[ARC]] are scanty. In the present work, we identified a genetic variation (F71L) in the exon-2 of [[CRYAA]] (alphaA-crystallin) gene in three unrelated female sporadic cases among 711 [[ARC]] patients but not in 265 normal non-cataractous controls by SSCP and RFLP analysis. By comparing human recombinant wild-type and F71L-alphaA-crystallin, we characterized the functional significance of this missense mutation. Chromatography, fluorescence and far- and near-UV CD studies indicated that F71L missense mutation did not significantly affect the apparent molecular mass, secondary and tertiary structures and hydrophobicity of alphaA-crystallin. While the mutant alphaA-crystallin displayed significant (35-90%) loss of chaperone-like activity (CLA) in thermal aggregation of carbonic anhydrase, betaL- and gamma-crystallins, it showed moderate (10-50%) loss in CLA in DTT-induced aggregation of insulin and lysozyme. This is the first report of an alphaA-F71L mutation being associated with [[ARC]] and suggests that [[ARC]] in individuals carrying this mutation (F71L) might be due to the overall loss of in vivo chaperone activity due to interaction with other environmental factors.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Amino Acid Substitution&lt;br /&gt;
* Base Sequence&lt;br /&gt;
* Case-Control Studies&lt;br /&gt;
* Cataract&lt;br /&gt;
* Chromatography, Gel&lt;br /&gt;
* Circular Dichroism&lt;br /&gt;
* DNA Mutational Analysis&lt;br /&gt;
* Electrophoresis, Polyacrylamide Gel&lt;br /&gt;
* Exons&lt;br /&gt;
* Female&lt;br /&gt;
* Genetic Predisposition to Disease&lt;br /&gt;
* Humans&lt;br /&gt;
* Light&lt;br /&gt;
* Male&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Molecular Sequence Data&lt;br /&gt;
* Mutant Proteins&lt;br /&gt;
* Mutation&lt;br /&gt;
* Protein Structure, Quaternary&lt;br /&gt;
* Scattering, Radiation&lt;br /&gt;
* Spectrometry, Fluorescence&lt;br /&gt;
* Time Factors&lt;br /&gt;
* Tryptophan&lt;br /&gt;
* alpha-Crystallin A Chain&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816373&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>